Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jan;298(1):H102-11.
doi: 10.1152/ajpheart.00316.2009. Epub 2009 Oct 23.

Nonanticoagulant heparin reduces myocyte Na+ and Ca2+ loading during simulated ischemia and decreases reperfusion injury

Affiliations

Nonanticoagulant heparin reduces myocyte Na+ and Ca2+ loading during simulated ischemia and decreases reperfusion injury

William H Barry et al. Am J Physiol Heart Circ Physiol. 2010 Jan.

Abstract

Heparin desulfated at the 2-O and 3-O positions (ODSH) decreases canine myocardial reperfusion injury. We hypothesized that this occurs from effects on ion channels rather than solely from anti-inflammatory activities, as previously proposed. We studied closed-chest pigs with balloon left anterior descending coronary artery occlusion (75-min) and reperfusion (3-h). ODSH effects on [Na(+)](i) (Na Green) and [Ca(2+)](i) (Fluo-3) were measured by flow cytometry in rabbit ventricular myocytes after 45-min of simulated ischemia [metabolic inhibition with 2 mM cyanide, 0 glucose, 37 degrees C, pacing at 0.5 Hz; i.e., pacing-metabolic inhibition (PMI)]. Na(+)/Ca(2+) exchange (NCX) activity and Na(+) channel function were assessed by voltage clamping. ODSH (15 mg/kg) 5 min before reperfusion significantly decreased myocardial necrosis, but neutrophil influx into reperfused myocardium was not consistently reduced. ODSH (100 microg/ml) reduced [Na(+)](i) and [Ca(2+)](i) during PMI. The NCX inhibitor KB-R7943 (10 microM) or the late Na(+) current (I(Na-L)) inhibitor ranolazine (10 microM) reduced [Ca(2+)](i) during PMI and prevented effects of ODSH on Ca(2+) loading. ODSH also reduced the increase in Na(+) loading in paced myocytes caused by 10 nM sea anemone toxin II, a selective activator of I(Na-L). ODSH directly stimulated NCX and reduced I(Na-L). These results suggest that in the intact heart ODSH reduces Na(+) influx during early reperfusion, when I(Na-L) is activated by a burst of reactive oxygen production. This reduces Na(+) overload and thus Ca(2+) influx via NCX. Stimulation of Ca(2+) extrusion via NCX later after reperfusion may also reduce myocyte Ca(2+) loading and decrease infarct size.

PubMed Disclaimer

Figures

Fig. 1.
Fig. 1.
Pharmacological postconditioning with 2-O, 3-O desulfated heparin (ODSH) reduces infarct size in ischemic-reperfused porcine myocardium. A: area at risk in the left ventricle (AAR/LV, left) and infarct size expressed as area of necrosis relative to the AAR (NEC/AAR). AAR was comparable in all groups. Infarct size was significantly reduced in the 15 mg/kg and 45 mg/kg ODSH groups. *P < 0.05 vs. control. B: myeloperoxidase activity (MPO) in ischemic-reperfused myocardium, expressed as Δabsorbance at 460 nm·min−1·g tissue−1 (A460·min−1·g tissue−1), was significantly reduced in the 45 mg/kg but not in 5 or 15 mg/kg ODSH groups. *P < 0.05 vs. other groups. ODSH 5, 5 mg/kg ODSH; ODSH 15, 15 mg/kg ODSH; ODSH 45, 45 mg/kg ODSH.
Fig. 2.
Fig. 2.
Effects of ODSH on [Ca2+]i during pacing-metabolic inhibition (PMI) in rabbit ventricular myocytes. PMI for 45 min caused a marked increase in [Ca2+]i, and the magnitude of the increase was reduced by ODSH at concentrations of 10 (ODSH 10) and 100 μg/ml (ODSH 100). *P < 0.05; **P < 0.01; vs. PMI; n = 7. ODSH 1, 1 μg/ml ODSH.
Fig. 3.
Fig. 3.
Influence of the Na+/Ca2+ exchange (NCX) inhibitor KB-R7943 (KBR) on [Ca2+]i during PMI, and on the effects of ODSH. KBR (10 μM) and ODSH (100 μg/ml) caused a similar reduction in [Ca2+]i, and in the presence of KB-R there was no further reduction in [Ca2+]i induced by exposure to ODSH. *P < 0.05 vs. PMI; n = 6.
Fig. 4.
Fig. 4.
Effects of ODSH on NCX current (INCX). A: ODSH (100 μg/ml) increased INCX over the voltage range of approximately −60 mV to +50 mV. B: Summary IV curve showing the stimulatory effect of ODSH on INCX. *P < 0.05; n = 5.
Fig. 5.
Fig. 5.
Effects of ODSH on [Na+]i during PMI. PMI caused a significant rise in [Na+]i, and this was reduced by exposure to 100 μg/ml ODSH. *P < 0.05 vs. HEPES control, **P < 0.05 vs. PMI; n = 6.
Fig. 6.
Fig. 6.
Influence of ranolazine (Ran) on [Ca2+]i during PMI, and on the effects of ODSH. Ran (10 μM) plus ODSH 100 (μg/ml) caused a similar reduction in [Ca2+]i, and in the presence of Ran there was no further reduction in [Ca2+]i induced by exposure to ODSH. *P < 0.05 vs. PMI; n = 7.
Fig. 7.
Fig. 7.
Effect of ODSH on the rise in [Na+]i-induced by exposure to sea anemone toxin II (ATX). Compared with control conditions [HEPES + pacing (HP)] exposure to ATX 10 nM caused a highly significant increase in [Na+]i, and this was reduced by exposure to 100 μg/ml ODSH. ODSH also caused a small but significant decrease in [Na+]i during control conditions (no ATX, HP alone). *P < 0.05, **P < 0.01 vs. HP; ***P < 0.01 vs. HP + ATX; n = 6.
Fig. 8.
Fig. 8.
Effects of ODSH on Na+ channel ionic currents (INA). A: peak Na+ current-voltage (I-V) relationships from a holding membrane potential (Vhp) of −150 mV; values in the presence of 1 mg/ml ODSH heparinic acid (○). All Na+ currents were normalized to the maximal inward INa in control. Lines represent the fits to the Boltzmann equation for peak intravenous relationships (see methods). For n = 6 cells, there were no significant differences between control and ODSH heparinic acid. Control values were maximal conductance (Gmax) = 1, voltage at the half point of the relationship (V1/2) = −57 ± 3 mV, and slope (s) = −6.3 ± 0.6. In ODSH heparinic acid values were Gmax = 1 ± 0.04, V1/2 = −57 ± 3 mV, and slope (s) = −6.4 ± 0.6 . B: peak I-V relationships from a holding potential of −110 mV for control (•) and in 1 mg/ml ODSH heparinic acid (○). All INa were normalized to the maximal inward INa in control. Lines represent the fits to the Boltzmann equation for peak intravenous relationships (see methods). For n = 6 cells, Gmax was significantly decreased from 1 to 0.87 ± 0.05 in ODSH heparinic acid, the slope was not significantly changed (−6.1 ± 0.7 in control vs. −6.2 ± 0.8 in ODSH heparinic acid), while there was a small leftward shift in the V1/2 in control (−57 ± 3 mV) compared with ODSH heparinic acid (−56 ± 3 mV). C: steady-state voltage-dependent Na+ channel availability (SSI) curves in control (•) and in 1 mg/ml ODSH heparinic acid (○). All INa in each cell were normalized to its Imax from the fit of a Boltzmann relationship to SSI curve in control (see methods). Lines represent the fits to the Boltzmann equation. For n = 6 cells, V1/2 was significantly shifted from −102 ± 5 mV in control to −104 ± 2 mV in ODSH heparinic acid. There were minimal but significant shifts in the slope from 7.4 ± 7 in control to 7.6 ± 6 in ODSH heparinic acid but not in Imax from 1 to 0.99 ± 0.01 in heparinic acid. D: late INa determined by saxitoxin subtraction of leak currents from a holding potential of −110 mV to step potentials from −100 to 20 mV (see methods) for 100 ms. •, means ± SE INa in control; ○ means ± SE in ODSH heparinic acid for 4 cells. Note the decrease in mean current in ODSH heparinic acid compared with control across the range of potentials. The values at −50, −40, and −30 mV were significantly different between control and ODSH heparinic acid.

References

    1. Antzelevitch C, Belardinelli L, Wu L, Fraser H, Qygmunt AC, Burashnikov A, Diego JM, Fish JM, Cordeiro JM, Goodrow RJ, Scornik F, Perez G. Electrophysiologic properties and antiarrhythmic actions of a novel antianginal agent. J Cardiovasc Pharmacol Ther 9, Suppl 1: S65–S83, 2004 - PubMed
    1. Amran MS, Homma N, Hashimoto K. Pharmacology of KB-R7943: a Na+-Ca2+ exchange inhibitor. Cardiovasc Drug Rev 21: 255–276, 2003 - PubMed
    1. Argaud L, Gateau-Roesch O, Muntean D, Chalabreysse L, Loufouat J, Robert D, Ovize M. Specific inhibition of the mitochondrial permeability transition prevents lethal reperfusion injury. J Mol Cell Cardiol 38: 367–374, 2005 - PubMed
    1. Bachhuber T, Almaca J, Aldehni F, Mehta A, Amaral MD, Schreiber R, Kunzelmann K. Regulation of the epithelial Na+ channel by the protein kinase CK2. J Biol Chem 283: 13225–13232, 2008 - PMC - PubMed
    1. Baines CP, Kaiser RA, Purcell NH, Blair NS, Osinska H, Hambleton MA, Brunskill EW, Sayen MR, Gottlieb RA, Dorn GW, Robbins J, Molkentin JD. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434: 658–662, 2005 - PubMed

Publication types

MeSH terms